chr2-46543059-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_012249.4(RHOQ):​c.13C>T​(p.Pro5Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

RHOQ
NM_012249.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.146

Publications

0 publications found
Variant links:
Genes affected
RHOQ (HGNC:17736): (ras homolog family member Q) This gene encodes a member of the Rho family of small GTPases, which cycle between inactive GDP-bound and active GTP-bound states and function as molecular switches in signal transduction cascades. Rho proteins promote reorganization of the actin cytoskeleton and regulate cell shape, attachment, and motility. The encoded protein is an important signalling protein for sarcomere assembly and has been shown to play a significant role in the exocytosis of the solute carrier family 2, facilitated glucose transporter member 4 and other proteins, possibly acting as the signal that turns on the membrane fusion machinery. Three related pseudogene have been identified on chromosomes 2 and 14. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13668528).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHOQNM_012249.4 linkc.13C>T p.Pro5Ser missense_variant Exon 1 of 5 ENST00000238738.9 NP_036381.2 P17081V9HWD0
RHOQXM_011532726.3 linkc.13C>T p.Pro5Ser missense_variant Exon 1 of 6 XP_011531028.1
RHOQXM_005264229.3 linkc.13C>T p.Pro5Ser missense_variant Exon 1 of 3 XP_005264286.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOQENST00000238738.9 linkc.13C>T p.Pro5Ser missense_variant Exon 1 of 5 1 NM_012249.4 ENSP00000238738.4 P17081
RHOQENST00000432183.5 linkn.13C>T non_coding_transcript_exon_variant Exon 1 of 3 5 ENSP00000393140.1 F8WET9
RHOQENST00000465198.1 linkn.155+1099C>T intron_variant Intron 1 of 1 3
RHOQENST00000489471.5 linkn.-90C>T upstream_gene_variant 5 ENSP00000428624.1 H0YB40

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000138
AC:
2
AN:
1449842
Hom.:
0
Cov.:
31
AF XY:
0.00000139
AC XY:
1
AN XY:
721240
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32060
American (AMR)
AF:
0.00
AC:
0
AN:
44110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25674
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38218
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85162
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4856
European-Non Finnish (NFE)
AF:
0.00000181
AC:
2
AN:
1107744
Other (OTH)
AF:
0.00
AC:
0
AN:
59860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 14, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.13C>T (p.P5S) alteration is located in exon 1 (coding exon 1) of the RHOQ gene. This alteration results from a C to T substitution at nucleotide position 13, causing the proline (P) at amino acid position 5 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.30
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.76
T
M_CAP
Pathogenic
0.78
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.80
N
PhyloP100
0.15
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.032
Sift
Benign
0.10
T
Sift4G
Uncertain
0.038
D
Polyphen
0.0
B
Vest4
0.058
MutPred
0.29
Gain of glycosylation at P5 (P = 0.0423);
MVP
0.64
MPC
0.74
ClinPred
0.19
T
GERP RS
2.8
PromoterAI
-0.072
Neutral
Varity_R
0.14
gMVP
0.22
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1667882386; hg19: chr2-46770198; API